Finance

Lists
GLAND:NSE
Gland Pharma Ltd
₹2,838.30
-0.71%
(-20.30) 1D
Aug 19, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAND...
Open
₹2,852.90
High
₹2,881.40
Low
₹2,827.50
Mkt. cap
468.22B
Avg. vol.
0.00
Volume
254.91K
Dividend
0.70%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
41.50
52-wk high
₹3,039.80
52-wk low
₹1,573.60
EPS
₹68.39
No. of employees
4K
Open
₹2,852.90
High
₹2,881.40
Low
₹2,827.50
Mkt. cap
468.22B
Avg. vol.
0.00
Volume
254.91K
Dividend
0.70%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
41.50
52-wk high
₹3,039.80
52-wk low
₹1,573.60
EPS
₹68.39
No. of employees
4K
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4.33K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteglandpharma.com
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹19.22 / ₹18.03
+6.58%beat
Revenue / Est. (INR)
18.00B / 17.56B
+2.52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.87B
16.95B
17.43B
18.00B
Cost of goods sold
6.04B
6.31B
8.32B
6.80B
Cost of revenue
6.04B
6.31B
8.32B
6.80B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.85B
4.24B
4.26B
4.44B
Operating expense
6.75B
7.37B
5.22B
7.42B
Total operating expenses
12.79B
13.68B
13.54B
14.22B
Operating income
2.08B
3.27B
3.89B
3.78B
Other non operating income
841.62M
631.73M
-1.79B
612.28M
EBT including unusual items
2.84B
3.62B
5.06B
4.35B
EBT excluding unusual items
2.84B
3.86B
5.02B
4.35B
Income tax expense
1.00B
1.01B
1.39B
1.18B
Effective tax rate
35.30%
27.79%
27.51%
27.13%
Other operating expenses
1.84B
2.06B
-130.22M
1.87B
Net income
1.84B
2.61B
3.67B
3.17B
Net profit margin
12.35%
15.42%
21.04%
17.61%
Earnings per share
11.15
16.98
22.23
19.22
Interest and investment income
-
-
2.06B
-
Interest expense
-78.23M
-39.30M
-63.09M
-43.61M
Net interest expenses
-78.23M
-39.30M
1.99B
-43.61M
Depreciation and amortization charges
1.06B
1.08B
1.09B
1.11B
EBITDA
3.11B
4.17B
4.91B
4.80B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps